No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents / therapeutic use
-
Humans
-
Interferon-alpha / adverse effects*
-
Interferon-alpha / therapeutic use
-
Kidney / blood supply*
-
Kidney / physiopathology
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Male
-
Middle Aged
-
Peripheral Vascular Diseases / chemically induced*
-
Renal Circulation
Substances
-
Antineoplastic Agents
-
Interferon-alpha